What is the equivalent fentanyl patch dose to a Butrans (buprenorphine) 10 mcg patch?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Butrans 10 mcg/h Buprenorphine Patch Equivalence to Fentanyl

A Butrans (buprenorphine) 10 mcg/h patch is approximately equivalent to a fentanyl 12.5 mcg/h patch, though this dose is not commercially available, so the closest available option would be a fentanyl 25 mcg/h patch with appropriate dose reduction and close monitoring.

Conversion Calculation

The conversion between buprenorphine and fentanyl patches requires working through oral morphine equivalents as an intermediary:

Step 1: Convert Buprenorphine to Oral Morphine Equivalent

  • Buprenorphine 10 mcg/h patch converts to approximately 7.5-13 mg oral morphine per day using the recommended conversion ratio of 75:1 to 110:1 1
  • For cancer pain patients or those requiring more aggressive dosing, the 75:1 ratio is more appropriate, yielding approximately 13 mg oral morphine equivalent per day 1
  • Using the more conservative 100:1 ratio yields approximately 10 mg oral morphine equivalent per day 1

Step 2: Convert Oral Morphine to Fentanyl Patch

  • The National Comprehensive Cancer Network recommends a 100:1 conversion ratio between oral morphine and transdermal fentanyl 2
  • Using 10-13 mg oral morphine equivalent: this translates to approximately 0.1-0.13 mcg/h fentanyl, which when multiplied by 100 equals 10-13 mcg/h fentanyl patch 3, 4

Practical Clinical Application

Available Dosing Options

  • The lowest commercially available fentanyl patch is 25 mcg/h 3, 4
  • Since the calculated equivalent (10-13 mcg/h) is not available, you must either:
    • Start with fentanyl 25 mcg/h and reduce by 25-50% of the calculated dose to account for incomplete cross-tolerance 3, 4
    • Consider that the patient may be under-dosed on buprenorphine 10 mcg/h if requiring conversion

Critical Safety Considerations

When converting from buprenorphine to fentanyl, you must account for buprenorphine's unique pharmacology:

  • Buprenorphine has extremely high mu-receptor affinity and dissociates slowly, which can block other opioids from binding 5
  • Allow adequate washout time (at least 24-48 hours) after removing the buprenorphine patch before applying fentanyl to avoid reduced fentanyl efficacy 6
  • Residual buprenorphine in the skin continues absorption for hours after patch removal 6

Monitoring Protocol

  • Provide short-acting opioid breakthrough medication for the first 8-24 hours until steady state is achieved 3, 4
  • Reassess pain control after 2-3 days when fentanyl reaches steady state 3, 4
  • Titrate based on average daily breakthrough medication requirements 4

Common Pitfalls to Avoid

  • Never apply heat to patients on fentanyl patches (fever, heating pads, electric blankets) as this accelerates absorption and can cause fatal overdose 3, 7
  • Do not use fentanyl patches for unstable pain requiring frequent dose changes 3, 4
  • Only use fentanyl patches in opioid-tolerant patients - a patient on buprenorphine 10 mcg/h qualifies as opioid-tolerant 4
  • The significant interpatient variability with buprenorphine conversions means clinical judgment and close monitoring are essential 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fentanyl Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fentanyl Infusion Dosing for Acute Pain Management in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.